Maven Securities’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
– Sell
-3,000
Closed -$788K – 667
2025
Q2
$788K Buy
+3,000
New +$731K 0.02% 493
2024
Q4
– Sell
-1,200
Closed -$268K – 941
2024
Q3
$268K Hold
1,200
– – 0.01% 799
2024
Q2
$244K Buy
+1,200
New +$244K 0.01% 831
2024
Q1
– Sell
-5,800
Closed -$1.32M – 698
2023
Q4
$1.32M Buy
5,800
+2,900
+100% +$609K 0.03% 404
2023
Q3
$583K Buy
+2,900
New +$612K 0.01% 770
2023
Q2
– Sell
-2,444
Closed -$482K – 970
2023
Q1
$482K Buy
+2,444
New +$503K 0.01% 664

Other funds holding LH

Maven Securities's LH Position: Q4 2024 in Review

Maven Securities sold out of Labcorp (LH) in Q4 2024, closing a stake of 1,005 shares — an estimated $225K sold.

Maven Securities first reported a position in LH in Q1 2023 and held it in 4 quarters. The position peaked at $307K in Q1 2023. 927 funds tracked by Wall St. Rank hold LH as of Q4 2024.

  • Maven Securities reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
  • Maven Securities sold 1,005 Labcorp shares in Q4 2024, an estimated $225K.
  • Maven Securities first reported a position in Labcorp in Q1 2023 and held it in 4 quarters.
  • Maven Securities's Labcorp position peaked at $307K in Q1 2023.
  • 927 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Maven Securities's 13F filing for Q4 2024, filed 14 Feb 2025.